Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-22-002076
Filing Date
2022-01-19
Accepted
2022-01-19 21:45:24
Documents
1
Period of Report
2022-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 1356
  Complete submission text file 0001140361-22-002076.txt   3016
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO NORTH NINTH STREET ALLENTOWN PA 18101
Business Address
Redman Heather B (Reporting) CIK: 0001887532 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-11460 | Film No.: 22540515